Dahlöf B - Search Results

1

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol.

Dahlöf B, Devereux RB, Kjeldsen SE, Julius S, Beevers G, de Faire U, Fyhrquist F, Ibsen H, Kristiansson K, Lederballe-Pedersen O, Lindholm LH, Nieminen MS, Omvik P, Oparil S, Wedel H; LIFE Study Group. Dahlöf B, et al. Lancet. 2002 Mar 23;359(9311):995-1003. doi: 10.1016/S0140-6736(02)08089-3. Lancet. 2002. PMID: 11937178 Clinical Trial.

2

Reversal of cardiovascular structural changes when treating essential hypertension. The importance of the renin-angiotensin-aldosterone system.

Dahlöf B, Herlitz H, Aurell M, Hansson L. Dahlöf B, et al. Am J Hypertens. 1992 Dec;5(12 Pt 1):900-11. doi: 10.1093/ajh/5.12.900. Am J Hypertens. 1992. PMID: 1337459 Clinical Trial.

3

Antihypertensive efficacy and side effects of three beta-blockers and a diuretic in elderly hypertensives: a report from the STOP-Hypertension study.

Ekbom T, Dahlöf B, Hansson L, Lindholm LH, Scherstén B, Wester PO. Ekbom T, et al. Among authors: dahlof b. J Hypertens. 1992 Dec;10(12):1525-30. doi: 10.1097/00004872-199210120-00013. J Hypertens. 1992. PMID: 1338084 Clinical Trial.

4

The stroke preventive effect in elderly hypertensives cannot fully be explained by the reduction in office blood pressure--insights from the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension).

Ekbom T, Dahlöf B, Hansson L, Lindholm LH, Odén A, Scherstén B, Wester PO. Ekbom T, et al. Among authors: dahlof b. Blood Press. 1992 Oct;1(3):168-72. doi: 10.3109/08037059209077513. Blood Press. 1992. PMID: 1345050 Free article. Clinical Trial.

5

Structural cardiovascular changes in essential hypertension. Studies on the effect of antihypertensive therapy.

Dahlöf B. Dahlöf B. Blood Press Suppl. 1992;6:1-75. Blood Press Suppl. 1992. PMID: 1345261

6

[Treatment of hypertension in Norway. Indications, therapeutic intensity and economic aspects].

Moan A, Kjeldsen SE, Enger E, Ibsen H, Dahlöf B, Lund-Johansen P. Moan A, et al. Among authors: dahlof b. Tidsskr Nor Laegeforen. 1992 Jan 10;112(1):69-70. Tidsskr Nor Laegeforen. 1992. PMID: 1553650 Norwegian.

7

Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension).

Dahlöf B, Lindholm LH, Hansson L, Scherstén B, Ekbom T, Wester PO. Dahlöf B, et al. Lancet. 1991 Nov 23;338(8778):1281-5. doi: 10.1016/0140-6736(91)92589-t. Lancet. 1991. PMID: 1682683 Clinical Trial.

8

[Antihypertensive treatment reduces the risk of stroke even in elderly hypertensive patients].

Dahlöf B, Ekbom T, Hansson L, Lindholm L, Scherstén B, Wester PO. Dahlöf B, et al. Lakartidningen. 1991 Dec 4;88(49):4229-30. Lakartidningen. 1991. PMID: 1758223 Swedish. No abstract available.

9

Key learnings from the STOP-Hypertension study: an update on the progress of the ongoing Swedish study of antihypertensive treatment in the elderly.

Hansson L, Dahlöf B, Ekbom T, Lindholm L, Scherstén B, Wester PO. Hansson L, et al. Among authors: dahlof b. Cardiovasc Drugs Ther. 1991 Jan;4 Suppl 6:1253-5. doi: 10.1007/BF00114229. Cardiovasc Drugs Ther. 1991. PMID: 2009249 Clinical Trial.

10

Regression of cardiovascular structural changes--a preventive strategy.

Dahlöf B. Dahlöf B. Clin Exp Hypertens A. 1990;12(5):877-96. doi: 10.3109/10641969009073506. Clin Exp Hypertens A. 1990. PMID: 2145096 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

399 results

Search Page

Filters